Avalere Health
An Inovalon Company

Market Access and Reimbursement

Optimize Access and Adoption

Today, an expanded universe of stakeholders are defining and evaluating the value of medical interventions beyond the requirements for FDA approval. Payers and providers develop utilization management strategies, including clinical pathways, appropriate use criteria, and bundled payments, to deliver value to the marketplace. Manufacturers also address evolving definitions of value by integrating customer needs and working with guideline and measure developers to ensure health outcome goals are met. Avalere looks at this complex world of commercialization through a single, yet multi-dimensional lens. We draw from policy expertise, private and public payer perspectives, patient and provider requirements, as well as a multitude of other stakeholders to create one integrated market strategy. Specifically, Avalere uses The Payer Edge®, our proprietary network of payer decision makers to inform your coverage and access action plan. From launching new technologies to navigating access challenges for existing products, we help you secure reimbursement and access.

What's Your Challenge?

  • Public and private payer landscape analysis
  • Distributor and specialty pharmacy strategies
  • Reimbursement tools: coding, pricing, contracting
  • Patient support services
  • Field team design and deployment strategy​

Complementary Products


Meet a few of our experts ready to partner with you.

All Staff

Reginald Williams

Senior Vice President


Reginald Williams, Senior Vice President, leads teams that deliver research, analytic, and strategic support to clients, with a focus on the needs of life sciences manufacturers and patient groups. He advises clients on medical technology policy, regulatory and market access strategies for new products, and the evolution of public and private payers' use of evidence for formulating coverage and reimbursement decisions, with a focus on the Medicare program.

Prior to joining Avalere, Reggie was a member of the health policy team at the National Academy of Social Insurance (NASI).He also served as the Howard R. Swearer Public Service intern in the Rhode Island Department of Health's Office of Minority Health.

Reggie has an AB in Biomedical Ethics from Brown University. He also serves on the board of directors of Mental Health America, a nonprofit dedicated to helping people live mentally healthier lives. He is a Patient-Centered Outcomes Research grant reviewer and a member of NASI and Health Technology Assessment International.

Geoffrey Storchan

Senior Manager


Geoffrey Storchan, Senior Manager, advises clients on reimbursement, policy and market access strategies for diagnostics, medical devices and pharmaceuticals companies. Geoffrey also has special expertise in the areas of oncology and endocrinology.

Prior to joining Avalere, Geoffrey was a Postdoctoral Fellow at the National Institutes of Health, contributing to studies on finding new targets and drugs for endocrine therapies. As a graduate student at Georgetown University, Geoffrey conducted research investigating the molecular mechanisms underlying breast cancer progression.

Geoffrey holds a BS in Biology from the University of Michigan and a MS and PhD from Georgetown University in Biochemistry and Molecular Biology.

Danielle Showalter

Senior Director


Danielle Showalter, Senior Director, advises clients on reimbursement, policy and market access strategies for diagnostic, medical device and pharmaceutical companies. Danielle provides a rich background in consulting and research services, particularly in the areas of physician payment, CPT® coding, device reimbursement strategies and diagnostic payment policy.

Prior to Avalere, Danielle was the Director of Health Policy and Reimbursement at ADVI, assisting diagnostic and device clients in developing and implementing coding, coverage and reimbursement strategies, as well as understanding the impact of regulatory and legislative changes. Danielle also worked for Altarum Institute, providing research support, expertise and primary IRB review for TRICARE. 

Danielle has a MA in Public Health from the George Washington University and a BA from the University of Virginia.

Kathy Hughes

Vice President


Kathy Hughes, Vice President, advises Avalere clients on value strategies, market access, and evidence planning.  Kathy partners with life sciences companies to scrutinize complex issues in market access, craft strategies and tactics to address them, and plan for and perform the analytics necessary for their success.

Prior to joining Avalere, Kathy was co-leader of the Market Access practice at Covance, and the Chief Operating Officer at Holy Cross Health Corp.  She has also served as Vice President for Corporate and Strategic Planning for Blue Shield of California, and Senior Manager with Ernst & Young’s Healthcare Management consulting practice.

Kathy has a BA from Brandeis University and a MBA from the University of Chicago.  She also has a Certificate of Completion from the Mid-Atlantic Health Leadership Institute at the Johns Hopkins Bloomberg School of Public Health and is a Senior Fellow at the Thomas Jefferson University School of Population Health.

« Back to Mobile Site